Amedeo Smart

Free Medical Literature Service


 

Amedeo

Diseases of the Thyroid

  Free Subscription

08.04.2024

1 Acta Cytol
1 BMC Cancer
1 Clin Cancer Res
2 Clin Nucl Med
1 Diagn Cytopathol
2 Eur Thyroid J
5 J Clin Endocrinol Metab
2 J Endocrinol Invest
1 J Nucl Med
1 PLoS One
3 Surgery
1 Thyroid



    Acta Cytol

  1. SHINOMIYA Y, Kouchi Y, Onodera K, Yamamoto H, et al
    Imprint Cytology of Tall Cell Carcinoma with Reversed Polarity of the Breast: A Case Report.
    Acta Cytol. 2024;68:73-79.
    >> Share


    BMC Cancer

  2. AWNY S, Abdallah A, Metwally IH, Abdelwahab K, et al
    Impact of age on central lymph nodes involvement in papillary thyroid cancer.
    BMC Cancer. 2024;24:423.
    >> Share


    Clin Cancer Res

  3. READ ML, Brookes K, Zha L, Manivannan S, et al
    Combined Vorinostat and Chloroquine Inhibit Sodium-Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo.
    Clin Cancer Res. 2024;30:1352-1366.
    >> Share


    Clin Nucl Med

  4. KUMAR SA, Mittal BR, Kumar S, Singh H, et al
    FDG PET/CT in the Diagnosis and After Sunitinib Follow-up of Synchronous Base of Tongue and Thyroid Metastases From Renal Cell Carcinoma.
    Clin Nucl Med. 2024;49:e208-e210.
    >> Share

  5. AK SIVRIKOZ I, Deveci H, Yildirim N
    A Rare False-Positive Whole-Body Scan in a Patient With Differentiated Thyroid Cancer: Unilateral Conjunctival Concretions.
    Clin Nucl Med. 2024;49:451-453.
    >> Share


    Diagn Cytopathol

  6. SIROTNIKOV S, Griffith CC, Lubin D, Zhang C, et al
    ThyroSeq overview on indeterminate thyroid nodules: An institutional experience.
    Diagn Cytopathol. 2024 Mar 30. doi: 10.1002/dc.25311.
    >> Share


    Eur Thyroid J

  7. RIIS T, Bonnema SJ, Brix TH, Folkestad L, et al
    Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study.
    Eur Thyroid J. 2024;13:e230181.
    >> Share

  8. KOSTOPOULOS G, Effraimidis G
    Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation.
    Eur Thyroid J. 2024;13:e230254.
    >> Share


    J Clin Endocrinol Metab

  9. NEWMAN SK, Tuttle RM
    Redefining actionable disease in well differentiated thyroid cancer management.
    J Clin Endocrinol Metab. 2024 Apr 4:dgae218. doi: 10.1210.
    >> Share

  10. LIU CQ, Shen CK, Du YX, Li ZM, et al
    Survival outcome and optimal candidates of primary tumor resection for patients with metastatic medullary thyroid cancer.
    J Clin Endocrinol Metab. 2024 Apr 4:dgae214. doi: 10.1210.
    >> Share

  11. LEE-SAXTON YJ, Egan CE, Bratton BA, Thiesmeyer JW, et al
    Low Mitotic Activity in Papillary Thyroid Cancer: A Marker for Aggressive Features and Recurrence.
    J Clin Endocrinol Metab. 2024 Mar 30:dgae203. doi: 10.1210.
    >> Share

  12. SAKO A, Matsuse M, Saenko V, Tanaka A, et al
    TERT promoter mutations increase tumor aggressiveness by altering TERT mRNA splicing in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 Apr 5:dgae220. doi: 10.1210.
    >> Share

  13. VILLAGELIN D, Cooper DS, Burch HB
    A 2023 International Survey of Clinical Practice Patterns in the Management of Graves' Disease: A Decade of Change.
    J Clin Endocrinol Metab. 2024 Apr 5:dgae222. doi: 10.1210.
    >> Share


    J Endocrinol Invest

  14. SCHUBERT L, Mbekwe-Yepnang AM, Wassermann J, Braik-Djellas Y, et al
    Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status.
    J Endocrinol Invest. 2024 Apr 5. doi: 10.1007/s40618-024-02352.
    >> Share

  15. SCAPPATICCIO L, Caruso P, Di Martino N, Ferrazzano P, et al
    Thymic hyperplasia is accurate to detect new-onset Graves' hyperthyroidism and resolves after restoring euthyroidism.
    J Endocrinol Invest. 2024 Mar 30. doi: 10.1007/s40618-024-02355.
    >> Share


    J Nucl Med

  16. GREENSPAN BS, Hofman MS, Buscombe J
    The Accomplishments and Legacy of Saul Hertz, MD.
    J Nucl Med. 2024;65:659-663.
    >> Share


    PLoS One

  17. JIN X, Yin Z, Li X, Guo H, et al
    TIM3 activates the ERK1/2 pathway to promote invasion and migration of thyroid tumors.
    PLoS One. 2024;19:e0297695.
    >> Share


    Surgery

  18. LEE-SAXTON YJ, Palacardo F, Greenberg JA, Egan CE, et al
    Radioactive iodine administration is not associated with improved disease-specific survival in classic papillary thyroid carcinoma greater than 4 cm confined to the thyroid.
    Surgery. 2024;175:215-220.
    >> Share

  19. WRIGHT K, Fisher JC, Rothberger GD, Prescott JD, et al
    Incidental (68)Ga-DOTATATE uptake in thyroid nodules: Is guideline-directed management still appropriate?
    Surgery. 2024;175:228-233.
    >> Share

  20. PAPAVRAMIDIS T, Chorti A, Cheva A
    Response to "Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy".
    Surgery. 2024 Apr 3:S0039-6060(24)00131-4. doi: 10.1016/j.surg.2024.
    >> Share


    Thyroid

  21. LAUFFER P, Heinen CA, Goorsenberg AWM, Malekzadeh A, et al
    Analysis of Serum Free Thyroxine Concentrations in Healthy Term Neonates Underlines Need for Local and Laboratory-Specific Reference Interval: A Systematic Review and Meta-Analysis of Individual Participant Data.
    Thyroid. 2024 Apr 2. doi: 10.1089/thy.2023.0562.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016